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 Measurement of radionuclides biodistribution in post-radioembolization 
90Y SIRT is a part of treatment evaluation, in which the assessment of 
biodistribution is used to evaluate the possible extrahepatic presence and 
the absorbed dose estimation for the tumor cells, healthy liver cells, and 
critical organs. As the dose-response analysis is performed based on this 
evaluation, the biodistribution measurement coming from post-imaging 
modality has a crucial role in achieving these goals. The two devices, 
Single Photon Emission Tomography (SPECT) and Positron Emission 
Tomography are discussed in some aspects, including the quality of 
quantitative images, performance characteristics, and absorbed dose 
considerations. 
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1. INTRODUCTION 
Radioembolization by Selective Internal 
Radiation Therapy (SIRT) using 90Y is a 
preferable treatment option for inoperable 
primary liver malignancy and colorectal 
metastases in the liver (Murthy et al., 2005). In 
these malignancies, external radiotherapy is not 
favorable due to liver cell intolerance and 
complications (such as hepatitis and progressive 
liver failure) after 30 Gy dose for liver (Stubbs 
& Wickremesekera, 2004). Yttrium-90 is a beta 
emitter with high energy (Eβmean=0.94 MeV) 
which can deliver a significant amount of dose 
(up to 80 Gy) and thus increase treatment 
efficacy (Pasciak, Bradley, & McKinney, 2017). 
The 90Y radionuclide along with its carrier 
substance is provided through catheters directly 
to the intrahepatic artery. The carrier element 
can be either in the form of resin or glass 
microsphere; each has its particular application. 
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Resin microsphere is aimed for primary 
colorectal cancer while glass microsphere is 
aimed for unresectable primary liver cancer 
(Giammarile et al., 2011). Since the liver is 
surrounded by many critical soft tissues and 
organs, a careful treatment planning is required 
to minimize potential complications. It was 
reported that extrahepatic accumulation of 90Y 
could lead to several side effects, such as 
ulceration, bleeding of the gastrointestinal track, 
and radiation pneumonitis (Leung TW, 1995; 
Murthy et al., 2007; Riaz et al., 2009). Due to 
the nature of malignant cells, in which they 
require more blood supply compared to the 
normal cell, there is a unique process which can 
be used as a basis for malignant treatment based 
on SIRT. The distinct character of malignant 
hepatic cells is that they obtain their blood 
supply mainly from the hepatic artery, while the 
normal hepatic cells get their blood supply from 
the portal vein (Biermann HR, 1951). Based on 
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this fact, a radioembolization method can be 
employed to target the malignant cells 
selectively.  
The procedure of radioembolization 
includes the restriction of arterial bifurcation 
connecting the malignant site to the adjacent 
organs (Lau et al., 2012). In doing so, first, 
vascular mapping and radioembolization 
processes are done by using a microcatheter 
guided by fluoroscopy. Second, to estimate the 
potential spreading of the radionuclide to the 
lung, an assessment of lung shunting fraction 
(LSF) by using a surrogate radiopharmaceutical 
(99Tc-MAA) is performed by using gamma 
camera for adjusting the activity administered to 
be given to the patient. There is a guideline from 
the manufacturer for each type of microsphere. 
For resin microspheres, there is no reduction of 
administered activity for LSF<10%, 20% 
reduction of 10-15% LSF, 40% reduction for 
15-20% LSF, and no treatment if the amount of 
LSF found to be higher than 20% (SIR-
Spheres®, Sirtex Medical, Lane Cove, 
Australia). For glass microspheres, there is no 
such reduction factor, but the activity is limited 
by the amount of lung dose, i.e. <30 Gy for a 
single treatment and <50 Gy for cumulative 
treatment (TeraSphere®, MDS Nordion, 
Canada). The third step is activity planning. 
There are several methods available, namely, 
the body surface area (BSA) method (Kao YH, 
2011), the partition model (PM) (Ho S, 1997), 
and medical internal radiation dosimetry 
(MIRD) (Gulec, Mesoloras, & Stabin, 2006; 
Stabin, 2006) for the resin microspheres. 
Whereas, for glass microsphere, the 
compartmental MIRD microdosimetry 
(Doherty, 2015) is used. Once the amount of 
activity has been decided, the 90Y microsphere 
is infused into the hepatic artery by 
microcatheter guided by fluoroscopy (Lau et al., 
2012). Following these steps, the treatment 
evaluation is performed after one day for the 
sake of three purposes. First, to assess the 
extrahepatic transfer of the radionuclide, 
second, to know the prognosis for the response 
of the lesion, and the last, to estimate absorbed 
dose obtained by both the cancerous and normal 
liver sites as well as the critical organs 
(Giammarile et al., 2011). 
A general formalism of the Medical Internal 
Radiation Dosimetry (MIRD) developed by the 
Society of Nuclear Medicine (SNM) takes into 
account several parameters, including the 
biodistribution of the radionuclide and the 
contributing physical factor, which are specified 
as time-integrated activity and S-value (Stabin, 
2008). Nowadays, the measurement of 
biodistribution uses a quantitative imaging 
approach which can provide a more accurate yet 
non-invasive procedure. Our particular concern 
in this review was to discuss the available tools 
for measuring biodistribution of activity in the 
post-treatment of 90Y SIRT based on 
quantitative imaging. The scope of the review 
was intentionally restricted only to Positron 
Emission Tomography (PET) and Single Photon 
Emission Tomography (SPECT) as these are the 
primary modalities which can quantify 
biodistribution of activity of 90Y microspheres 
in multiple views, which cannot be obtained in 
planar imaging, such as the gamma camera. It is 
of our interest because the biodistribution of 
activity can affect absorbed dose accuracy 
estimation and will guide the assessment of 
treatment efficacy, the decision for additional 
dose for the patient, and dose-response analyses 
(Stabin, 2008).  
2. MATERIALS AND METHODS 
2.1 Current Techniques For 90y Imaging 
Yttrium-90 is a common therapeutic 
radionuclide which can be produced via 
89Y(n,γ)90Y reaction in a nuclear reactor, or via 
the 90Sr decay. Figure 1 shows the decay of 90Y 
to 90Zr which emits beta particles as the major 
decay scheme. It has a half-life of 2.6684 days, 
beta energy of 2.28 MeV (max) and 0.937 MeV 
(mean), tissue penetration depth of 11 mm 
(max) and 2.5 mm (mean) which make it 
suitable to irradiate the size of either metastatic 
or primary tumor in the liver (Bé, 2006). Also, 
the 90Y decays completely within 13 days, a 
desirable characteristic that provides the 
maximum balance between treatment time and 
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patient safety. 
Fig 1.  The decay scheme of 90Y to 90Zr. Although 
the majority of 90Y decays via β- emission, there is a 
small portion of decay via the excitation state of 
90Zr (E=1.76 keV) with branching ratio of 
(3.186±0.047)×10-5. The picture was reproduced 
based on Selwyn, Nickles, Thomadsen, DeWerd, & 
Micka, 2007. 
 At the beginning of the use of 
radioembolization 90Y SIRT, there was common 
knowledge that 90Y was a pure β- emitter and 
that was the reason why SPECT is the only 
choice to measure the biodistribution of 90Y 
through the bremsstrahlung photons produced 
by the interaction between β- and tissue (Bailey 
& Willowson, 2013). Though people realized 
that the image quality is relatively poor for 
quantitative measurement, SPECT was still 
extensively used for post-treatment evaluation 
as no other option was available. Despite the fact 
that Ford had predicted the 0+–0-  transition of 
90Zr producing β+ and been experimentally 
discovered by Johnson, et al. in 1955 (Ford, 
1955; Johnson O, 1955), it still needs a long way 
to go until the PET-based quantitative 
measurement was started to be carried out. The 
existence of β+ decay even with a very small 
branching ratio (3.186±0.047)×10-5 (Selwyn, 
Nickles, Thomadsen, DeWerd, & Micka, 2007) 
leads to internal pair production interaction 
between β+ and the β-, thus producing two 
annihilation photons with the same energy 
(~511 keV) in the opposite direction. This 
process is the basis of PET imaging (Saha, 
2016).  
 The discussion below elaborates general 
technical issues of SPECT and PET in the use of 
90Y biodistribution measurement, it highlights 
the active use of each, and reminds the possible 
remaining challenges to be improved in both 
systems.  
2.2 Spect 
Several investigations had been carried out 
to evaluate SPECT-based post-
radioembolization measurement which is still 
facing many problems (Elschot M, 2011; L. M. 
Minarik D, Segars P, Gleisner KS, 2009; S.-G. 
K. Minarik D, Linden O, Wingardh K, Tennvall 
J, et al, 2010). Since the indirect bremsstrahlung 
x rays is a continuous spectrum which lacks 
photopeaks (Elschot M, 2011), the 
discrimination of counts based on the energy of 
the photon becomes difficult. As an effort to 
improve the SPECT sensitivity, a large energy 
window is required (Elschot M, 2011), which at 
the same time, allows for more noise caused by 
background radiation and scatter photons 
(Cherry, Sorenson, & Phelps, 2012). The 
resulted contrast also get reduced with the use of 
collimator septa, a mechanical aperture made of 
lead. The collimator septa are needed for 
locating the counting events, but at the same 
time, its existence also allows for high energy 
photon penetration and thus degrades the image 
quality (Elschot M, 2011). All those factors that 
eventually influence the overall performance 
characteristics of SPECT are examined in detail 
in the next section. 
Some studies tried to improve the image 
quality of SPECT by concerning the following 
ways. The first is to find the optimal energy 
windows, either using Monte Carlo (MC) 
simulation of the full energy spectrum (Heard, 
2004; Rault, Staelens, Holen, Beenhouwer, & 
Vandenberghe, 2010) or phantom studies 
(Minarik, Gleisner, & Ljungberg, 2008). 
Second, by modeling of the image degrading 
factor, which can be done by employing the 
simulation of imaging nuclear detector 
(SIMIND) (Rong, Du, Ljungberg, et al., 2012) 
or again, the MC simulation-based modeling 
(Elschot, Lam, Bosch, Viergever, & Jong, 
2013). Based on the studies previous studies, it 
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can be figured out that the optimal energy 
windows for detection of 90Y are in the middle 
energy range of approximately 100-150 keV, 
100-160 keV, or 90-125 keV, respectively 
(Heard, 2004; Rong, Du, & Frey, 2012; Shen S, 
1994). The lower energy range (70-100 keV) is 
mainly resulted by characteristics photon 
coming from the lead collimator, while the 
higher energy range (200-300 keV) and >300 
keV mostly comes from backscattering and 
septal penetration, respectively (Heard, 2004). 
The latter approach by modeling of degrading 
factors yields a significantly better image 
contrast, from 25% to 88% for the 37 mm sphere 
and less count error detection from 73% to 15%, 
accompanied by the increase of noise (Mattijs 
Elschot et al., 2013).  
Though the SPECT system suffers from 
poor sensitivity and spatial resolution, there are 
some counter facts, which in turn makes SPECT 
is advantageous in some cases (Bailey & 
Willowson, 2013). As the SPECT radionuclides 
have longer half-lives, there is no urgency of 
placing a medical cyclotron near the SPECT 
facility. A simultaneous multi-tracer study is 
also possible when it is needed to assess two or 
more radionuclide biokinetics in a single 
session. Lastly, the SPECT system requires less 
investment as compared to PET and has the 
greater use worldwide. 
 
2.3 PET 
The current practice of post-
radioembolization 90Y SIRT imaging was firstly 
initiated by Nickles et al. in 2004 by using 
phantom studies (Nickles et al., 2004), while the 
clinical study was firstly performed by Lhommel 
et al. in 2009 (Lhommel et al., 2009). Later, a 
PET-based dosimetry was confirmed to be 
feasible with the additional Time of Flight (TOF) 
(Lhommel et al., 2010) or even without the TOF 
installation (Werner et al., 2009). Indeed, the 
utilization of TOF is likely producing a better 
estimation of dose as investigated by several 
groups (Attarwala et al., 2014; Carlier et al., 
2015; Elmbt, Vandenberghe, Walrand, Pauwels, 
& Jamar, 2011; Martí-Climent et al., 2014; 
Willowson, Forwood, Jakoby, Smith, & Bailey, 
2012; Willowson, Tapner, & Bailey, 2015). It is 
because the use of TOF improves the sensitivity 
and spatial resolution due to its ability to provide 
high coincidence time resolution and accurate 
coincidence location detection (Walrand, Hesse, 
Renaud, & Jamar, 2015). The TOF design itself 
has been much developed for the last three 
decades, where the coincidence time resolution 
gets reduced from 650 ps in the first prototype, 
down to 320 ps in the latest digital TOF-PET, 
each providing the annihilation location 
prediction within 9 cm and 4.5 cm, respectively 
(Surti & Karp, 2016). The improvement of TOF-
PET system nowadays is the result of the 
utilization of lutetium-based crystal (Lutetium 
oxy-orthosilicate, LSO, and lutetium–yttrium 
oxy-orthosilicate, LYSO), which is better than 
bismuth germinate (BGO) crystal in term of 
faster decay time and higher photon to light 
conversion output (Surti & Karp, 2016). 
There are several promising facts to support 
the capability of PET in the use of 90Y imaging. 
First, as the annihilation photons have 
approximately uniform energy (~511 keV), the 
discrimination window may easier to 
distinguish the true coincidence, despite the 
possibility of scattering, random, and multiple 
coincidences, and thus producing better 
sensitivity and spatial resolution. Second, the 
maximum positron energy of 90Y is 758 keV that 
is comparable to the 633 keV of 18F (Bailey DL, 
2003). Consequently, the correction techniques 
including scatter, random, and attenuation 
correction are expected to be clinically suitable 
for the well-established correction procedure for 
18F (van Elmbt L, 2010).  
As a functional imaging tool, it is well 
understood that PET also suffers from several 
limitations which degrade the accuracy of its 
measurement (IAEA, 2014). Naturally, the 
positrons travel a certain distance (~4 mm) 
before the annihilation events occur (Cherry et 
al., 2012). It inevitably produces an uncertainty 
in events location detection. The other issue is 
the probability of block effect or depth of 
interaction (J., 2013). In this phenomena, the 
interaction of annihilation photon does not only 
take place in the corresponding two detectors 
but also penetrate in the neighboring detectors 
which end up in the wrong line of response 
(LOR) (J., 2013). Furthermore, there is also a 
possible non-collinearity detection between the 
two annihilation photons direction. This effect 
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may significantly affect the resolution for the 
larger ring diameter (Cherry et al., 2012). The 
other case is that the spatial resolution is not 
uniform for the whole field of view (FOV). 
Instead, the highest resolution is achieved in the 
middle of FOV and getting worse towards the 
periphery (Cherry et al., 2012). As the spatial 
resolution is characterized by point spread 
function (PSF), there is a so-called PSF 
algorithm included in the image reconstruction 
process to improve the spatial resolution 
(Rahmim, Qi, & Sossi, 2013).  
IMAGE QUALITY IN QUANTITATIVE 
IMAGING 
Description of image quality in quantitative 
imaging can usually be made based on several 
aspects, including spatial resolution, contrast, 
noise, and detectability (M. Elschot et al., 2013). 
Representative images of SPECT and PET are 
illustrated in Fig. 2. In general, PET images can 
provide a better representation of the lesion 
shape and higher activity uptake as compared to 
SPECT images (Y.-H. Kao et al., 2013).  
Fig 2.  Large heterogeneous liver lesions shown in 
three different modalities. (a, b) Catheter-directed 
CT angiogram (c, d) 90Y PET/CT (e, f) 90Y 
bremsstrahlung SPECT/CT. This picture was 
reproduced from Kao et al., 2013.   
3. RESULTS AND DISCUSSION 
3.1 Spatial Resolution 
The spatial resolution is defined as the 
ability to distinguish two adjacent points and 
characterized by the full width half maximum 
(FWHM). An insufficient spatial resolution 
produces the blurring and also lead to partial 
volume effect which may reduce quantitative 
accuracy (Soret, Bacharach, & Buvat, 2007). 
Investigation of image resolution performed 
based on 90Y SPECT yields the range of 11.4 – 
12.5 mm (for a source to detector distance of 6 – 
6.5 mm) (Elschot M, 2011; Shen S, 1994). 
Meanwhile, the image resolution of PET laid 
between 2.2 – 12.1 mm (Attarwala et al., 2014; 
Carlier et al., 2015; Elmbt et al., 2011; Martí-
Climent et al., 2014; Willowson et al., 2012; 
Willowson et al., 2015), respectively. However, 
this value may differ between each type of 
device, the type of microsphere used, the type of 
scintillator crystal, and the reconstruction 
parameter as shown in Table III. Nevertheless, in 
general, the spatial resolution of PET is still 
superior relatively compared to SPECT. 
 
Contrast and Noise 
Elschot et al. compared the contrast and 
noise in the two imaging modalities (Mattijs 
Elschot et al., 2013). The contrast recovery and 
noise are the parameters of interest because it 
affects the distinction of the lesion object and the 
adjacent background. They employed several 
methods to assess the influence of PSF algorithm 
and the additional TOF to the resulted images. 
For all methods, the iterative reconstruction was 
set. The results are shown in Fig. 3 and Fig. 4.  
Fig 3.  Contrast recovery as a function of sphere 
diameter for all reconstruction methods used in 
SPECT and PET. This picture was taken from 
Elschot, et al., 2013. 
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Fig 4.  SPECT and PET contrast recovery and image 
noise. A. Contrast recovery and image noise in the 
22-mm sphere for all reconstruction methods, B. 
SPECT image (iterative+PSF), C. PET 
(iterative+PSF+TOF), D. PET (iterative+PSF+TOF) 
reconstructed with SPECT-like noise level.  
The picture was taken from Elschot et al., 2013. 
 According to Fig. 3, the overall images 
showed that the contrast recovery was higher for 
the PET image, where the highest contrast was 
achieved by the iterative+PSF+TOF and 
followed by the iterative+PSF method. In 
contrary, the use of PSF algorithm did not give 
any difference to the contrast recovery of 
SPECT. In line with the contrast recovery 
parameter, noise levels are also significantly 
higher in the PET images where the 
incorporation of PSF algorithm and TOF 
notably reduced the noise level. Ideally, it is 
desired to have a sufficient contrast with less 
noise presence. Therefore, the post-
reconstruction processing was performed and 
obtained the PET image (iterative+PSF+TOF) 
with the SPECT-like noise level to establish 
better contrast and noise composition. 
3.2 Detectability  
The detectability comparison between 
SPECT and PET was demonstrated according to 
two criteria, i.e. Rose criterion for false negative 
detection and the method described by Elschot et 
al. (Mattijs Elschot et al., 2013) to analyze the 
detectability in the intra- and extrahepatic 
biodistribution accumulation simulated in a 
phantom. Though the Rose criterion results 
indicate that all sites in the intra- and 
extrahepatic are visible, the other method 
denoted different outcomes. While the 
extrahepatic site remained visible up to as small 
as 28 mm in the diameter in PET image, all 
spheres in SPECT did not. In the intrahepatic 
site, the detectability thresholds are 13 and 22 
mm for PET and SPECT, respectively. After all, 
this analysis signifies the superiority of the PET 
over SPECT in detecting the intra- and 
extrahepatic arteries. 
 
PERFORMANCE CHARACTERISTICS 
The excellence of quantitative imaging 
system can also be evaluated based on their 
performance characteristics. There are several 
measures, including spatial resolution, 
sensitivity, recovery coefficient, image 
uniformity, count rate linearity, calibration 
factor, and convergence of the image 
reconstruction algorithm (Cherry et al., 2012; J., 
2013). This review will cover the comparison of 
SPECT and PET characteristics in term of spatial 
resolution and sensitivity. 
 
3.3 SPECT Characteristics 
Elschot et al. characterized the spatial 
measurement and sensitivity of SPECT and 
listed in Table I-II. In their research, a material 
called polymethylmethacrylate or PMMA was 
placed in the position between the source and 
detector to create the realistic condition of 
electron scattering. The data were taken based on 
several different object-to-source distances, 
namely, 2, 6, and 11 cm was set for 1 cm of 
scattering material, and 11 cm for 5 and 10 cm 
of scattering material.  Two kinds of windows 
were used, which consisted of a broad (50-250 
keV) and a smaller (120-250 keV) energy 
windows. There were also two types of 
collimator used, medium-energy (MEGP) and 
high-energy-multi-purpose (HEGP) collimators 
(Elschot M, 2011). The spatial resolution and 
sensitivity were then determined according to 
NEMA guideline (Association, 2007), where the 
sensitivity was obtained by the ratio of acquired 
counts and the true activity measured in a dose 
calibrator. The sensitivity was calculated for two 
positions, 10 cm and 40 cm from the detector 
(Elschot M, 2011).  
In Table I, the number on the outside and 
inside the bracket showed the FWHM and 
FWTM, respectively. The spatial resolution is 
substantially better when the source-detector-
distance is kept remained close. Also, the use of 
smaller energy window (120-250 keV) and the 
HEGP collimator notably produced preferable 
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spatial resolution (smaller FWHM) (Elschot M, 
2011). The result in this study was in line with 
another publication by Shen et al., in which they 
obtained FWHM of 12.5 mm measured at 6.8 
mm source-object-distance in the energy 
window of 55-285 keV (Shen S, 1994). 
Meanwhile, the nearest setting in the Elschot et 
al.’s work provided FWHM of 11.4 mm (Elschot 
M, 2011). 
Table 1. Spatial resolution of SPECT-based 90Y imaging 
 90Y 120-250 keV 90Y 50-250 keV 
 MEGP HEGP MEGP HEGP 
S01D0
2 
11.5(173.7) 7.0(113.1) 10.9(123,2) 7.5(49.2) 
S01D0
6 
12.9(222.2) 11.0(137.2) 11.4(149.7) 11.1(60.2) 
S01D1
1 
17.1(286.1) 15.3(160.0) 15.8(172.9) 15.4(57.6) 
S05D1
1 
19.7(300.6) 16.4(218.9) 19.4(235.7) 17.0(159.3) 
S10D1
1 
28.1(341.2) 18.1(269.5) 26.3(294.9) 20.1(241.3) 
     
The spatial resolution is written in mm unit.  
S01D02 corresponds to the measurement with 1 cm of 
scatter material and line-source to collimator distance of 
2 cm, S01D06 to the measurement with 1 cm of scatter 
material and line-source to collimator distance of 6 cm, 
etc. 
This table was reproduced based on Elschot, et al., 2011. 
 
The sensitivity obtained here was also 
consistent with another publication where they 
obtained 11.6 and 6.75 cps MBq-1 for MEGP 
and HEGP, in the broad energy window (Shen 
S, 1994). As may be expected, the broad energy 
window yielded higher sensitivity as 
consequence of involvement of scattering 
fraction and background counts. For the same 
energy window, the MEGP collimator produced 
higher sensitivity than the HEGP (Elschot M, 
2011; Shen S, 1994).  
 
Table 2. Sensitivity of SPECT-based 90Y Imaging  
 90Y 120-250 keV 90Y 50-250 keV 
 MEGP HEGP MEGP HEGP 
S – 10 cm (cps MBq-1) 6.0 3.1 10.5 6.0 
S – 40 cm (cps MBq-1) 3.0 1.8 6 4.9 
     
This table was reproduced based on Elschot, et al., 2011. 
 
 
3.4 PET Characteristics 
Many authors have recently reported 
investigations on PET spatial resolution with 
different modification factors as summarized in 
Table III. The assessment of spatial resolution in 
PET is commonly performed by using NEMA 
guideline NU 2-2007 (Association, 2007). The 
choice of the scintillation crystal, the utilization 
of TOF, reconstruction parameter seemed to be 
a matter of the final spatial resolution results. As 
stated before, the LSO is a good material for the 
PET detector design (Surti & Karp, 2016). 
Accompanied by a high number of iteration and 
subsets, though without TOF, the resolution of 
90Y PET imaging can reach 2.5 to 4 mm 
resolution (Gates, Esmail, Marshall, Spies, & 
Salem, 2010). 
The sensitivity determination also takes 
into account the true activity from dose 
calibrator measurement. Later, the counts 
reported in the PET system is divided by the true 
activity to obtain the sensitivity value, the same 
calculation performed in SPECT. Some factors 
are influencing the determination of sensitivity, 
such as detection efficiency, source-detector 
geometrical position, and acquisition mode (2D, 
with septa, or 3D, without septa). The detection 
efficiency concerns on conversion from photon 
to light, and is affected by some parameters, 
including scintillation decay time, atomic 
number, density, and the thickness of the 
scintillation material (Cherry et al., 2012).  
The sensitivity of 90Y PET was measured 
by several authors (Bagni et al., 2012; Ng et al., 
2013; Werner et al., 2009). The absolute 
sensitivity measured using Biograph mCT-
TrueV with TOF was 0.403 and 0.388 cps MBq-
1 in the center of FOV and 10 cm of the FOV, 
respectively (Martí-Climent et al., 2014). 
Another work by Bagni et al. performed by 
using GE Discovery ST PET/CT provided 
similar results, which are 0.409 and 0.577 cps 
MBq-1 for the same position setting (Bagni et al., 
2012). In comparison with the well-known 18F, 
the sensitivity of 90Y is much smaller, about four 
order below the sensitivity of 18F ( 0.5 versus 9 
cps MBq-1) (D'Arienzo et al., 2012). It can be 
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explained by the fact that the positron 
abundance of 90Y is only 32 per one million 
decays, whereas the 18F gains almost 967 per 
1000 decays (Pasciak et al., 2017).  
 
Table 3. Spatial Resolution of PET-based 90Y Imaging as the results of different acquisition and reconstruction 
methods 
Reference 90Y MICROSPHERE 
Scanner 
manufacturer 
Detector 
crystal 
Acquisition mode Reconstruction Resolution 
Lhommel et al. 
(2010) 
(Lhommel et al., 
2010) 
Resin microsphere Gemini Phillips LYSO TOF 2 iterations, 33 substeps - 
Werner et al. 
(2010) (Werner 
et al., 2009) 
Resin Microspheres Biograph Hi-Rez 
Siemens 
LSO Non TOF 8 iterations 16 subsets 
and 4 iterations 8 
subsets 
6.4 mm 
Gates et al 
(2011) (Gates et 
al., 2010) 
Glass microspheres Biograph 40 Siemens LSO Non TOF 3 iteration, 21 subsets 2.5 – 4 mm 
Wissmeyer et al. 
(2011) 
(Wissmeyer et 
al., 2011) 
Glass microspheres Philips Gemini 
PET/MR 
LYSO TOF 3 iterations, 33 subsets - 
Bagni et al. 
(2011) (Bagni et 
al., 2012) 
Resin microspheres Discovery ST GE BGO Non TOF 2 iterations, 15 subsets 6.3 mm 
Carlier et al. 
(2013) (Carlier 
et al., 2015) 
Resin microspheres Biograph mCT 40 
Siemens 
LSO TOF and Non TOF 1 or 3 iterations, 21 or 
24 subsets 
- 
Elschot et al. 
(2013) (Mattijs 
Elschot et al., 
2013) 
Resin microspheres Biograph mCT 
Siemens 
LSO TOF 3 iterations, 21 or 24 
subsets 
- 
Kao et al. (2012) 
(Y. e. a. Kao, 
2012) 
Resin microspheres Biograph WO 
Siemens 
LSO Non TOF 2 iterations, 8 subsets - 
Kao et al. (2013) 
(Mattijs Elschot 
et al., 2013) 
Resin microspheres Discovery 690 GE LYSO TOF 3 iterations, 18 subsets 10 – 12 mm 
van Elmbt 
et al. (2011) 
(Elmbt et al., 
2011) 
Resin microspheres Philips Gemini TF LYSO TOF 3 iterations, 8 subsets 9.3 mm 
van Elmbt 
et al. (2011) 
(Elmbt et al., 
2011) 
Resin microspheres Philips Gemini 
Power16 
GSO Non TOF 3 iterations, 8 subsets 10 mm 
van Elmbt 
et al. (2011) 
(Elmbt et al., 
2011) 
Resin microspheres Siemens Ecat Exact 
HRb 
BGO Non TOF 3 iterations, 8 subsets 10.6 mm 
Martí-Climent 
et al. (2014) 
(Martí-Climent 
et al., 2014) 
Resin microspheres Biograph mCT-
TrueV 
LSO TOF 1–3 iterations, 21–24 
subsets 
2.2 – 12.1 mm 
 
 
This table was reproduced based on Pasciak AS, et al., 2017.
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ABSORBED DOSE CONSIDERATION 
Image-based quantitative dosimetry was 
performed for both SPECT (iterative+PSF) and 
PET (iterative+PSF+TOF) images in both 
phantom and patient studies (M. Elschot et al., 
2013). For phantom dosimetry, due to the small 
size of ROIs, they encountered PVE, and thus, a 
corrected dose was also estimated. The results 
were compared to the true value which was 
determined based on high-resolution CT data. 
The results were shown in Fig. 5-6 and Table 
IV-V. Among all cumulative dose volume 
histograms (CDVHs) in the phantom study, the 
PET sphere CDVH appeared to be the closest to 
the true CDVH. The PET sphere CDVH was a 
bit differ to the true sphere CDVH in the form 
of the flat curve because it was influenced by the 
substantially higher noise in the PET image. 
Also, the overall dose measured based on PET 
(corrected and uncorrected dose) consistently 
showed the least difference to the true value. For 
instance, the smallest diameter measured by 
SPECT and PET achieved -75% (+69%) and -
45% (+40%) dose difference to the true value, 
respectively. As the PVE did not strongly affect 
large diameter, the dose difference tends to be 
lower, which are -58% (+18%) and -11% (+6%) 
for SPECT and PET, respectively. Analog to 
CDVH results, the patient dosimetry showed 
more significant dose difference between the 
low dose (LD) and high dose (HD) in the PET-
based dose estimation. For example, the dose 
difference in the SPECT-dose map (Fig. 5B) and 
PET-dose map (Fig. 5C) are 39 and 73 Gy. It 
was also supported by the substantial gap 
between the PET HD and SPECT HD CDVHs 
curves. According to this result, it was 
concluded that the high-resolution PET with the 
TOF installation and PSF reconstruction 
algorithm likely produced a better image of 90Y 
distribution in post-radioembolization imaging. 
 
 
 
 
 
 
 
 
 
 
Table 4. Phantom Dosimetry 
Phantom ROI (mm) 
 10 13 17 22 28 37 Background 
SPECT 76 
(516) 
69 
(514) 
78 
(511) 
102 
(487) 
143 
(484) 
181 
(508) 
61 
PET 167 
(431) 
224 
(432) 
255 
(433) 
333 
(475) 
324 
(426) 
384 
(457) 
60 
TRUE 306 341 372 395 412 432 52 
        
This table was repreoduced based on Elschot, et al.,2013. 
Fig 5.  Phantom dosimetry. CDVH of the phantom 
background ROI and the ROI of the 37-mm diameter 
sphere. The presented doses were not corrected for 
PVE. The figure was taken from Elschot, et al., 
2013. 
 
Table 5. Patients dosimetry 
Phantom ROI (mm) 
 1 2 3 4 5 
 L
D 
H
D 
L
D 
H
D 
L
D 
H
D 
L
D 
H
D 
L
D 
H
D 
SPEC
T 
26 37 34 73 30 53 22 36 12 31 
PET 29 85 38 11
1 
33 80 26 58 11 47 
           
The mean dose (Gy) in the low-dose ROI (LD) and the 
high-dose ROI (HD) are given for all patients. This table 
was repreoduced based on Elschot, et al., 2013. 
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Fig 6.  Patient dosimetry. The CDVH of the whole liver (WL), low-dose (LD) and high-dose (HD) ROIs of patient 
2 (A), a transversal slice through the SPECT-based dose map, fused with CT (B), and the same transversal slice 
through the PET-based dose map (C). The boundary of the high dose ROI is depicted by the green line. The figure 
was taken from Elschot, et al., 2013. 
 
4. CONCLUSION AND REMARKS 
 The emerging use of 90Y 
Radioembolization SIRT needs a reliable post-
treatment imaging modality because of its 
function to produce a quantitative image as the 
basis of dose estimation and dose-response 
analyses. In term of image quality, considering 
the spatial resolution, noise, contrast, and 
detectability, the high-resolution PET-based 
image well demonstrates these parameters 
relatively compared to the SPECT-based image. 
The high-resolution PET may be achieved by 
the installation of TOF, the use of the iterative 
algorithm with a high number of subsets and 
iterations, the use of PSF algorithm, and the 
utilization of lutetium-based scintillation 
crystal. In contrast to the large underestimation 
or overestimation of dose in SPECT-based 
dosimetry, the PET dosimetry seemed to be 
closer to the true value. When the high-
resolution PET is used, the dose estimation still 
needs to consider the correction of PVE which 
may exist for the small lesion site.  
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